Catalyst Wire Dossier Catalyst Wire Dossier

JINARC

tolvaptan · Otsuka Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for JINARC, covering 2015-02-27 to 2026-08-19. Get the full timeline:

Most recent: EMA Authorised: Jinarc (tolvaptan) — Otsuka Pharmaceutical Netherlands B.V.

See pricing